Skip to main content
Log in

Histological subtypes of ductal carcinomain situ of the breast

  • Original Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

It has become common to divide ductal carcinomain situ (DCIS) of the breast into two main groups, comedo or noncomedo by tumor morphology. But noncomedo DCIS can be further stratified into several morphological patterns that exhibit several different growth patterns and most DCIS lesions have more than one pattern. In this study, DCIS elements were classified by morphological pattern and the association between predominant or recessive elements of DCIS lesions and clinicopathological findings was evaluated.

Methods

DCIS lesions from 46 patients were studied regarding the histological architectural patterns: comedo, cribriform, papillary, solid and micropapillary. The predominant architectural pattern which comprised more than 50% of the cells of the cancerous lesion was defined as the major element of the tumor and minor elements consisted of less than 50% but more than 25% of cells comprising the tumor.

Results

Of 24 tumors containing a comedo pattern as the major or minor element, 9 (38%) had microscopic intraductal spread over 2 cm and 11 (46%) had involvement of lobules, which was significantly higher than that observed in other types. Of 20 tumors containing a cribriform pattern as the major or minor element, 8 (40%) had microscopic intraductal spread over 2 cm and 9 (45%) had involvement of lobules, which was significantly higher than that seen in other types. Of 10 tumors containing a papillary type as the major or minor element, 5 (50%) had discrete multicentric lesions in the ipsilateral or contralateral breast, which was significantly higher than that seen in other types.

Conclusions

DCIS lesions containing a comedo or cribriform element are more likely to have microscopic spread and involvement of lobules and DCIS lesions containing a papillary element are likely to be multicentric, whether the pattern are predominant in the tumor or not.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DCIS:

Ductal carcinomain situ

References

  1. Lennington WJ, Jensen RA, Dalton LW,et al: Ductal carcinoma in situ of the breast: heterogeneity of individual lesions.Cancer 73: 118–124, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Patchefsky AS, Schwartz GF, Finkelstein SD,et al: Heterogeneity of intraductal carcinoma of the breast.Cancer 63: 731–741, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. McDivitt RW, Stewart FW, Berg JW: Tumor of the breast. In: Harlan I, Feminger MD eds, Atras of Tumor Pathology, Armed Forces Institute of Pathology, Washington DC, ppl33–137, 1986.

    Google Scholar 

  4. The Consensus Conference Committee: Consensus conference on the classification of ductal carcinoma in situ.Cancer 80: 1798–1802, 1997.

    Article  Google Scholar 

  5. Lagios MD, Westdahl PR,et al: The concept and implications of multicentricity in breast carcinoma.Pathol Ann 16: 83–102, 1981–9.

    CAS  Google Scholar 

  6. Lagios MD, Margolin FR, Westdahl PR,et al: Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.Cancer 63: 618–624, 1989.

    Article  PubMed  CAS  Google Scholar 

  7. Lagios MD, Westdahl PR, Margolin FR,et al: Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures.Cancer 50: 1309–1314, 1982.

    Article  PubMed  CAS  Google Scholar 

  8. Silverstein MJ, Cohlan BF, Gierson ED,et al: Duct carcinoma in situ: 227 cases without microinvasion.Eur J Cancer 28: 630–634, 1992.

    Article  PubMed  CAS  Google Scholar 

  9. Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 12the ed, Kanehara Publications, Tokyo, 1996 (in Japanese).

    Google Scholar 

  10. Noguchi M, Tsugawa K, Taniya T,et al: The outcome of patients with breast cancer who underwent breast conserving treatment with or without immediate volume replacement with autogenous tissue.Breast Cancer 6: 43–50, 1999.

    Article  PubMed  Google Scholar 

  11. Silverstein MJ, Waisman JR, Gamagami P,et al: Intraductal carcinoma of the breast (208 cases): Clinical factors influencing treatment choice.Cancer 66: 102–108, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Bur ME, Zimarowski ML, Schnitt SJ: Estrogen receptor immunohistochemistry in carcinoma in situ of the breast.Cancer 69: 1174–1184, 1992.

    PubMed  CAS  Google Scholar 

  13. Schwartz GF, Finkel GC, Garcia JC,et al: Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.Cancer 70: 2468–2474, 1992.

    Article  PubMed  CAS  Google Scholar 

  14. Solin LJ, Recht A, Fourquet A,et al: Ten-year results of breast conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast.Cancer 68: 2337–2344, 1991.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideyuki Ajisaka.

Additional information

Reprint requests to Hideyuki Ajisaka, Department of Surgery II, School of Medicine, Kanazawa University, Takara-machi 13-1, Kanazawa 920-0934, Japan.

About this article

Cite this article

Ajisaka, H., Tsugawa, K., Noguchi, M. et al. Histological subtypes of ductal carcinomain situ of the breast. Breast Cancer 9, 55–61 (2002). https://doi.org/10.1007/BF02967548

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967548

Key words

Navigation